World's Best Scientists 2026 revealed!
Journal of Oncology Pharmacy Practice
H-index 9

Journal of Oncology Pharmacy Practice

1078-1552

Published by: SAGE

https://journals.sagepub.com/home/opp

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 2653 58 57 8

Additional Metrics

Number of Best Scientists*: 80
Documents by Best Scientists*: 79
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 47
SCIMAGO SJR: 0.424
Impact Factor: N/A

Overview

Top Research Topics at Journal of Oncology Pharmacy Practice?

The journal facilitates discussions on Internal medicine, Oncology, Cancer, Chemotherapy and Intensive care medicine. The studies on Internal medicine discussed can also contribute to research in the domains of Gastroenterology and Surgery. The Oncology works featured in Journal of Oncology Pharmacy Practice incorporate elements from Pharmacy, Colorectal cancer, Clinical trial and Immunotherapy.

Journal of Oncology Pharmacy Practice connects research in Cancer with the related topic of Family medicine. The work on Family medicine presented in the journal focuses on Pharmacist in particular.

  • Internal medicine (42.65%)
  • Oncology (28.23%)
  • Cancer (16.16%)

What are the most cited papers published in the journal?

  • Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade. (126 citations)
  • Management of hand-foot syndrome induced by capecitabine. (120 citations)
  • Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. (114 citations)

Research areas of the most cited articles at Journal of Oncology Pharmacy Practice:

The journal papers explore disciplines such as Internal medicine, Chemotherapy, Pharmacology, Oncology and Surgery. Issues in Internal medicine were discussed in the most cited papers, taking into consideration concepts from other disciplines like Gastroenterology and Pharmacist. The journal articles focus on Chemotherapy but sometimes tackle the closely related topic of Intensive care medicine which is concerned with MEDLINE.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

Journal of Oncology Pharmacy Practice is organized to address concerns in the fields of Internal medicine, Oncology, Cancer, Cancer research and Chemotherapy. While Journal of Oncology Pharmacy Practice primarily focused on Internal medicine, it also opened dialogues on the discipline of In patient. In it, Nivolumab, Immunotherapy, Disease and Toxicity are investigated in conjunction with one another to address concerns in Oncology research.

Topics in Cancer were tackled in line with various other fields like Family medicine and Intensive care medicine. Journal of Oncology Pharmacy Practice features Cancer research research that overlaps with concepts in Immune checkpoint inhibitors. The journal is mostly focused on Lung cancer, specifically Non small cell.

The most cited articles from the last journal are:

  • Fibroblast growth factor receptor (FGFR) inhibitors: A review of a novel therapeutic class. (8 citations)
  • Safety of ninety-minute daratumumab infusion. (5 citations)
  • Metastatic penile squamous cell carcinoma with dramatic response to combined checkpoint blockade with ipilimumab and nivolumab. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Oncology Pharmacy Practice (based on the number of publications) are:

  • Carole R Chambers (39 papers) published 8 papers at the last edition,
  • Mário L de Lemos (38 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Constantin A Dasanu (34 papers) absent at the last edition,
  • Peter J Gilbar (32 papers) published 6 papers at the last edition, 2 more than at the previous edition,
  • Constantin A Dasanu (25 papers) published 9 papers at the last edition, 6 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Oncology Pharmacy Practice (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (56 papers) published 3 papers at the last edition the same number as at the previous edition,
  • University of North Carolina at Chapel Hill (34 papers) published 2 papers at the last edition, 8 less than at the previous edition,
  • Alberta Health Services (33 papers) published 11 papers at the last edition, 10 more than at the previous edition,
  • University of California, San Diego (33 papers) published 10 papers at the last edition, 3 more than at the previous edition,
  • BC Cancer Agency (32 papers) published 1 paper at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 16.26% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 13.83% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.51% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.36% of all publications and 63.30% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Interdisciplinary Impact and Collaboration in Research

An essential aspect of the Journal of Oncology Pharmacy Practice is its interdisciplinary nature. The research discussed often stretches beyond the confines of Oncology and Medicine, intersecting with other fields like Pharmacy, Gastroenterology, and Surgery. In particular, several studies discussed in the journal open dialogues on the discipline of Nursing as well, indicating a significant overlap between these fields. The integration of Nursing in Oncology research indicates that collaborations are extremely beneficial, often leading to new insights and advancements in both fields. To further understand the role of nursing in oncology and how it might contribute to the research covered in this journal, one might consider looking into the current research and studies being carried out in the top nursing schools. For instance, the [best nursing schools in Alabama](https://research.com/degrees/best-nursing-schools-in-alabama) are known for their strong emphasis on integrating advanced nursing practices in Oncology. Continuing to foster these interdisciplinary collaborations in research will not only push the boundaries of knowledge but also improve practical outcomes in healthcare. Going forward, the Journal of Oncology Pharmacy Practice is likely to continue being a crucial platform for the development, discussion, and dissemination of such collaborative and interdisciplinary research efforts in the field of Oncology.

Top Publications

  • Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.

    Najeebah A Bade;Crystal Lu;Ciera L Patzke;Ciera L Patzke;Maria R Baer

    (2020)
    30 Citations
  • New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature:

    Lukas Delasos;Christopher Bazewicz;Aleksandra Sliwinska;Nerea Lopetegui Lia

    (2021)
    16 Citations
  • Safety of ninety-minute daratumumab infusion.

    Jeffrey Lombardi;Mathieu Boulin;Madeline Devaux;Amélie Cransac

    (2021)
    14 Citations
  • A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy

    Katherine McGee;Neil J Stone;Shikha Wadhwani;Yashpal S Kanwar

    (2021)
    13 Citations
  • Proactive risk assessment of vincristine use process in a teaching and referral hospital in Kenya and the implications

    Emmanuel K Kurgat;Irene Weru;David Wata;David Wata;Brian Godman;Brian Godman;Brian Godman

    (2020)
    10 Citations
  • Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab

    (2022)
    9 Citations
  • Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2)

    Homa Seyedmirzaei;Homa Seyedmirzaei;Mahsa Keshavarz-Fathi;Mahsa Keshavarz-Fathi;Sepideh Razi;Sepideh Razi;Masoumeh Gity;Masoumeh Gity

    (2021)
    9 Citations
  • Global changes to the chemotherapy service during the covid-19 pandemic

    (2021)
    9 Citations
  • Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy

    (2022)
    8 Citations
  • Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.

    Kyle Zacholski;Bryan Hambley;Erin Hickey;Sarah Kashanian

    (2021)
    8 Citations

Related Online Degrees & Career Pathways

For those interested in the broader healthcare field beyond traditional medical school, there are several valuable online education options available. Many students explore cheap medical billing and coding classes online as an affordable and flexible way to enter healthcare administration or support roles. These programs teach essential skills for managing patient records and healthcare billing efficiently.

Nursing also presents a practical career pathway, with many seeking accessible programs to start their journey. If you’re concerned about acceptance rates, researching nursing programs with high acceptance rates can help identify schools where admission is more attainable, without compromising education quality.

For those aiming to combine healthcare knowledge with leadership skills, pursuing a healthcare administration online degree provides accelerated pathways to management roles. These courses offer a comprehensive understanding of healthcare systems, policy, and organizational operations.

Additionally, exploring healthcare administration courses can be a cost-effective way to gain specialized knowledge, improving job prospects and career advancement in hospitals, clinics, and related healthcare organizations.

Best Scientists Contributing to This Journal